Why the study?
Does a mandatory formulary switch from nifedipine GITS to amlodipine maintain blood pressure control in patients on stable antihypertensive therapy?
Does a mandatory formulary switch from nifedipine GITS to amlodipine maintain blood pressure control in patients on stable antihypertensive therapy?
A mandatory formulary switch from nifedipine GITS to amlodipine safely maintained identical blood pressure control in a veteran population.
Answers are grounded in this paper and cite their sources.
Formulary switch maintained BP control in this veteran cohort; hypothesis-generating and requires randomized confirmation before practice change.
OBJECTIVE: To analyze retrospectively the effects on blood pressure (BP) control of a mandatory switch from nifedipine in the gastrointestinal therapeutic system (GITS) to amlodipine. DESIGN: Retrospective review of a randomized sample of medical records to assess the safety and efficacy of the medication change. All outpatient pharmacy prescriptions (n=525) had been converted over the course of a year by the patients' clinicians to amlodipine when the current refills for nifedipine GITS had expired. We reviewed a randomized sample of patients' medical records (n=182). SETTING: The Brockton/West Roxbury Veterans Administration Medical Center. PATIENTS: Patients on a stable dose of nifedipine GITS for three months or more before switching and on a stable dose of amlodipine for three months or more. MAIN OUTCOME MEASURES: The average of at least two outpatient BP measures was used as a measure of efficacy. RESULTS: Of the 86 patients who fulfilled the study criteria, 72 (84%) converted directly to amlodipine with no change in concomitant medications, and 14 had changes in concomitant medications related to BP response (seven had dose increases and seven neutral or decreased doses). In the 72 patients who were directly converted to amlodipine (all men, mean age 70 +/- 9 years), BP control did not change. Before the switch, BP averaged 140 +/- 14/77 +/- 9 mm Hg; after, it averaged 140 +/- 15/78 +/- 8 mm Hg (p=NS). After the switch, 22% of these patients were on monotherapy, 46% were taking one antihypertensive agent, and 32% were taking two or more antihypertensive medications; these percentages were similar to those when patients were taking nifedipine GITS. Similar BP responses were observed among patients 65 years of age (n=54). The mean dose of nifedipine GITS was 62 +/- 28 mg/d and of amlodipine 7.8 +/- 4 mg/d. Four patients discontinued amlodipine due to documented adverse events. CONCLUSION: A large group of patients, including older individuals and those on multiple antihypertensive medications, can be safely converted from nifedipine GITS to amlodipine. The medication switch resulted in identical BP control in the large majority of patients, infrequent concomitant medication changes, and few drug discontinuations.
No takes yet. Share an insight, caveat, or question.
Alexis et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: